NCT06104163

Brief Summary

The present retrospective study aims to evaluate the impact of cantilever design in the posterior areas of the mandible on clinical, radiographic, and volumetric parameters with an 8-year follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
8.6 years until next milestone

First Submitted

Initial submission to the registry

July 25, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 27, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 27, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 27, 2023

Completed
Last Updated

May 9, 2024

Status Verified

May 1, 2024

Enrollment Period

8.9 years

First QC Date

July 25, 2023

Last Update Submit

May 7, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Probing Depth of the Peri-implant Pocket (PPD)

    It is measured from the mucosal margin to the bottom of the probable peri-implant sulcus and expressed in mm.

    8 years

  • Plaque Index (PI)

    Evaluation of Plaque index (PI), expressed as the percentage of positive sites and measured at 4 implant sites (mesio-buccal, mesio-oral, disto-buccal and disto-oral) throught Michigan-grade periodontal probe.

    8 years

  • Keratinized mucosa (KM)

    Evaluation of Keratinized mucosa width (KM), measured from the restoration margin to the mucogingival junction and expressed in mm.

    8 years

  • Mucosal recession (MR)

    Mucosal recession (MR), of the peri-implant soft tissue, measured from the restoration margin to the mucosal margin and expressed in mm. Coronal from restoration margin is defined as (+) and apical from restoration margin defined as (-);

    8 years

  • Bleeding and/or suppuration on probing (BOP/SUP)

    Evaluation of Bleeding and/or suppuration on probing (BOP/SUP), within 30 seconds after probing and expressed as the percentage of positive sites and measured at 4 implantation sites (mesio-buccal, mesio-oral, disto-buccal and disto-oral).

    8 years

Secondary Outcomes (2)

  • Volumetric analysis at baseline and after 8 years of follow-up

    8 years

  • Radiographic examination at baseline and after 8 years of follow-up

    8 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with partial edentulism, treated comprehensively and continuously between 2015 and 2023, were enrolled at the School of Dentistry of the Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy, and a private outpatient regimen.

You may qualify if:

  • Patients aged ≥18 years;
  • Patients with partial edentulism;
  • Patients with systemic health or controlled medical conditions;
  • Patients with healthy or treated periodontal conditions;
  • Patients enrolled in regular supportive periodontal therapy (SPT);
  • Patients without clinical signs of oral parafunctions (bruxism or clenching);
  • Presence of 1 osteointegrated dental implant in posterior region (premolar or molar) of mandible, after transmucosal placement and healing at 3-6 months;
  • Tissue level solid-screw implants with a sand-blasted and acid etched (SLA) surface with an endosseous diameter of 4.1 mm, a length of 8, 10 or 12 mm, a shoulder diameter of 4.8 mm and a supracrestal machined neck with a height of 1.8 mm (Straumann Dental Implant System, Institute Straumann AG); Use of prefabricated titanium abutments;
  • Monolithic zirconia SCs manufactured by digital flow; Screwed SCs with a mesial or distal cantilever extension;
  • Alternative crown design (ACD) with eccentric implant insertion, with crown-like-premolar and with distal or mesial cantilever with ovoid conformation. In the latter case, the lower abutment cross-section in the region between the crown-bridge connector mimics the shape of a root, creating an "interradicular" access route to facilitate oral hygiene maneuvers;
  • Absence of occlusal contacts or guidance on the cantilever extension at baseline;
  • Opposing dentition consisting of natural teeth or fixed or removable restorations;
  • Availability of periapical radiography at baseline (i.e., loading of SCs) and at the analyzed timings (after 1, 3, 5, and 8 years);
  • Availability of clinical measurements, such as pocket probing depth (PPD), plaque index (PI), bleeding index at probing (BOP), suppuration at probing (SUP), keratinized mucosa (KM), and mucosal recession (MR) taken at baseline (i.e., at loading of the SCs) and at 8 years after SCs loading, at four sites/implant with a Michigan graded periodontal probe (Deppeler SA); Availability of intraoral scans at baseline (i.e., at loading of the SCs) and at the analyzed time points (after 1, 3, 5, and 8 years after SCs loading) and executed using 3 Shape TRIOS 3, Germany GmbH.

You may not qualify if:

  • Untreated or active periodontal diseases;
  • Type I implant placement;
  • SCs with cantilever extension replacing mandibular and maxillary incisors and canines; - - SCs with cantilever extension replacing posterior maxillary;
  • SCs with cantilever extension supported by implants with a diameter ≤3.5 mm;
  • SCs supported by hollow-screw and hollow-cylinder implants;
  • Technical complications, such as fractures of implants, abutments, and the prosthetic artifact;
  • Smoking habit (more than 15 cigarettes/day);
  • Drug or alcohol abuse;
  • Uncontrolled systemic diseases that could affect bone remodeling during implant osseointegration; or soft tissue healing (e.g., uncontrolled diabetes mellitus with HbA1c\>7, osteoporosis);
  • Use of medications that could affect bone remodeling during implant osseointegration or soft tissue healing (e.g., steroids, antiresorptive medication, radiotherapy);
  • Autoimmune and/or inflammatory diseases affecting the oral cavity;
  • Neurological or psychiatric handicap that could interfere with oral hygiene;
  • Pregnancy or lactation periods.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOU Policlinico G. Rodolico

Catania, 95124, Italy

Location

Study Officials

  • Gaetano Isola

    University of Catania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

July 25, 2023

First Posted

October 27, 2023

Study Start

January 1, 2015

Primary Completion

November 27, 2023

Study Completion

November 27, 2023

Last Updated

May 9, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations